| (+)-Carbovir |
|
|
|
|
| (+)-Carbovir triphosphate |
|
|
|
|
| (+)-Dihydrocalanolide A |
|
|
|
|
| (+)-PM 92131 |
|
|
|
|
| (-)-6-Aminocarbovir |
|
|
|
|
| (-)-Lentiginosine |
|
|
|
|
| (-)-Rabdosiin |
|
|
|
95.0% |
| (1R)-Tenofovir amibufenamide |
|
|
|
98.13% |
| (2RS)-FPMPA |
|
|
|
|
| (2S,5S)-Censavudine |
|
|
|
98.12% |
| (5R)-5-Hydroxytriptolide |
|
|
|
99.67% |
| (Cys47)-HIV-1 tat Protein (47-57) |
|
|
|
|
| (D-Ala)-Peptide T |
|
|
|
|
| 2-Hydroxycinnamic acid |
|
|
|
99.86% |
| 2-Hydroxycinnamic acid-d4 |
|
|
|
|
| (R)-Edelfosine |
|
|
|
99.9% |
| (R,R)-Abacavir |
|
|
|
|
| (Rac)-Efavirenz |
|
|
|
|
| (Rac)-Emtricitabine S-oxide |
|
|
|
|
| (Rac)-Saphenamycin |
|
|
|
|
| (Rac)-Telinavir |
|
|
|
|
| (Rac)-Tenofovir-d6 |
|
|
|
99.82% |
| (rel)-Lopinavir-d8 |
|
|
|
|
| (S)-Batylalcohol |
|
|
|
99.86% |
| (S)-BMS-378806 |
|
|
|
|
| (S)-Tenofovir |
|
|
|
98.34% |
| (threo)-Indinavir |
|
|
|
|
| (Z)-Rilpivirine |
|
|
|
|
| (Z)-9-Propenyladenine |
|
|
|
97.21% |
| (±)-BI-D |
|
|
|
98.06% |
| (±)-PM 92131 |
|
|
|
|
| (±)-trans-Lamivudine |
|
|
|
|
| 019854-B06 |
|
|
|
|
| 1,2-Didocosahexaenoyl-sn-glycero-3-phosphocholine |
|
|
|
97.3% |
| 1,3,5-Tricaffeoylquinic acid |
|
|
|
|
| 1,6-Di-O-galloyl-β-D-glucose |
|
|
|
91.11% |
| 1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide |
|
|
|
99.91% |
| 1-Deoxymannojirimycin hydrochloride |
|
|
|
99.85% |
| 12-Bromododecanoic acid |
|
|
|
98.0% |
| 12-Methoxydodecanoic acid |
|
|
|
|
| 12-Oxocalanolide A |
|
|
|
|
| 148.1-38m sodium |
|
|
|
|
| 16,16-Dimethyl prostaglandin A1 |
|
|
|
|
| 18A |
|
|
|
|
| 18BIOder |
|
|
|
|
| 1E7-03 |
|
|
|
95.07% |
| 2′,3′-Dideoxy-5-ethyluridine |
|
|
|
|
| 2',3'-Dideoxyadenosine |
|
|
|
99.96% |
| 2'-Deoxy-2'-fluoroarabinoadenosine |
|
|
|
99.91% |
| Indoline |
|
|
|
99.89% |
| 2,4-Dihydroxypyridine |
|
|
|
99.96% |
| 2-Phenylbutanoic acid |
|
|
|
99.90% |
| 2-Bromoaldisine |
|
|
|
|
| 2-Hydroxyacetophenone |
|
|
|
99.88% |
| 2-Phenylbutyric acid-d5 |
|
|
|
|
| 2F5 epitope |
|
|
|
|
| 3′-Azido-2′,3′-dideoxy-CTP |
|
|
|
|
| 3′-Azido-2′,3′-dideoxyuridine |
|
|
|
99.59% |
| 3'-Azido-3'-deoxy-5-methylcytidine |
|
|
|
99.90% |
| 3-Deazaadenosine hydrochloride |
|
|
|
99.59% |
| 3-O-Methylviridicatin |
|
|
|
|
| 3-Oxobetulin acetate |
|
|
|
|
| Moronic acid |
|
|
|
98.6% |
| 3-Deazaadenosine |
|
|
|
98.53% |
| 3β-Hydroxy-27-p-Z-coumaroyloxyurs-12-en-28-oic acid |
|
|
|
|
| 4''-O-Acetylafzelin |
|
|
|
|
| 4'-Ethynyl-2'-deoxyadenosine |
|
|
|
|
| Tucaresol |
|
|
|
97.50% |
| 4-Deoxy-4α-phorbol |
|
|
|
|
| 4-Isocyanato-TEMPO,Technical grade |
|
|
|
|
| 4-Nitrobenzofuroxan |
|
|
|
|
| 5-(N,N-Hexamethylene)-amiloride |
|
|
|
99.14% |
| 5-CITEP |
|
|
|
|
| 5-Hydroxynoracronycine |
|
|
|
|
| 5-Fluorouracil-15N2 |
|
|
|
99.53% |
| 5-Fluorouracil-13C,15N2 |
|
|
|
|
| 5-Fluorouracil-13C4,15N2 |
|
|
|
|
| 5-Fluorouracil-d1 |
|
|
|
99.9% |
| Valproic acid-d7 sodium |
|
|
|
|
| 5M038 |
|
|
|
|
| 7-Deaza-2',3'-dideoxyguanosine |
|
|
|
98.02% |
| 9-Aminoacridine-13C6 |
|
|
|
|
| 9-Aminoacridine |
|
|
|
99.35% |
| [(Cys(Bzl)84,Glu(OBzl)85)]CD4 (81-92) |
|
|
|
|
| A-75925 |
|
|
|
|
| a-D-Galactose-1,2-13C2 1-phosphate potassium |
|
|
|
|
| A3N19 |
|
|
|
|
| Abacavir carboxylate |
|
|
|
|
| Abacavir hydrochloride |
|
|
|
|
| ABBV-744 |
|
|
|
99.97% |
| Acopafant |
|
|
|
|
| Acyclovir triphosphate sodium (100 mM) |
|
|
|
99.61% |
| Adenallene |
|
|
|
|
| Aeroplysinin 1 |
|
|
|
95.0% |
| Agrocybin |
|
|
|
|
| AGS-009 |
|
|
|
|
| AIC-292 |
|
|
|
|
| Ainuovirine |
|
|
|
|
| AL-470 |
|
|
|
|
| Alizarin complexone |
|
|
|
98.0% |
| Alloc-DOX |
|
|
|
98.40% |
| AMD 3329 octahydrobromide |
|
|
|
|
| AMD 3465 |
|
|
|
98.24% |
| AMD 3465 hexahydrobromide |
|
|
|
98.0% |
| AMD-3329 |
|
|
|
|
| Amphotericin B methyl ester |
|
|
|
83.37% |
| Amprenavir-13C6 |
|
|
|
|
| Amtabafusp alfa |
|
|
|
99% |
| Amustaline dihydrochloride |
|
|
|
95.0% |
| Ancriviroc |
|
|
|
|
| anti-HIV agent 1 |
|
|
|
|
| Anti-HIV gp120 Antibody (55-36) |
|
|
|
|
| Anti-Mouse CD4 Antibody (YTS 191) |
|
|
|
|
| Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) |
|
|
|
99.5% |
| Antitumor agent-191 |
|
|
|
|
| Antiviral agent 29 |
|
|
|
|
| Antiviral agent 45 |
|
|
|
|
| Antiviral agent 55 |
|
|
|
90.0% |
| Antiviral agent 56 |
|
|
|
97.65% |
| Antiviral agent 62 |
|
|
|
|
| Antiviral agent 9 |
|
|
|
|
| APA-APA-MPO dihydrochloride |
|
|
|
|
| APA-H-MPO hydrochloride |
|
|
|
|
| Apelin-12 |
|
|
|
99.83% |
| Apelin-17(human, bovine) |
|
|
|
98.71% |
| Apelin-17(human, bovine) TFA |
|
|
|
|
| Apelin-36(human) |
|
|
|
98.01% |
| Apelin-36(human) TFA |
|
|
|
99.42% |
| Apelin-36(rat, mouse) |
|
|
|
98.59% |
| Apelin-36(rat, mouse) TFA |
|
|
|
|
| Aplaviroc |
|
|
|
|
| Aplaviroc hydrochloride |
|
|
|
99.94% |
| APOBEC3G-IN-1 |
|
|
|
96.88% |
| Aprepitant-13C2,d2 (Major) |
|
|
|
|
| Apricitabine |
|
|
|
99.8% |
| Artoheteronin |
|
|
|
|
| ASF-006 sodium |
|
|
|
|
| Asterriquinone |
|
|
|
|
| Asuptegravir |
|
|
|
|
| Atevirdine |
|
|
|
98.69% |
| Atevirdine mesylate |
|
|
|
|
| ATPase-IN-6 |
|
|
|
|
| ATTO 647 NHS ester |
|
|
|
|
| Aureothin |
|
|
|
|
| AzddMeC |
|
|
|
98.96% |
| AZT triphosphate |
|
|
|
|
| AZT triphosphate TEA |
|
|
|
|
| AZT triphosphate tetraammonium |
|
|
|
99.25% |
| AZT-P-ddI |
|
|
|
|
| Azt-pmap |
|
|
|
99.85% |
| Azvudine |
|
|
|
99.79% |
| Azvudine hydrochloride |
|
|
|
99.19% |
| B07 |
|
|
|
|
| Baculiferin A |
|
|
|
|
| Bavtavirine |
|
|
|
|
| BDM-2 |
|
|
|
99.09% |
| BEA 005 |
|
|
|
|
| Benanomicin A |
|
|
|
|
| beta-L-D4A |
|
|
|
99.71% |
| Betulin diacetate |
|
|
|
95.0% |
| BI 224436 |
|
|
|
98.01% |
| BI-2540 |
|
|
|
|
| Bictegravir |
|
|
|
99.93% |
| Bictegravir sodium |
|
|
|
99.62% |
| Bictegravir-d4 |
|
|
|
|
| Bictegravir-d5 |
|
|
|
|
| Bictegravir-d7 |
|
|
|
|
| BILA 1906 BS |
|
|
|
|
| BILR 355 |
|
|
|
|
| BIT-225 |
|
|
|
98.87% |
| BM 21.1298 |
|
|
|
|
| BMMP |
|
|
|
|
| BMS 186318 |
|
|
|
|
| BMS 488043 |
|
|
|
|
| BMS 561390 |
|
|
|
|
| BMS-378806 |
|
|
|
98.94% |
| BMS-585248 |
|
|
|
|
| BMS-663749 |
|
|
|
|
| BMS-663749 lysine |
|
|
|
|
| BMS-707035 |
|
|
|
99.99% |
| BMS-818251 |
|
|
|
99.36% |
| BNM-III-170 |
|
|
|
98.48% |
| BNM-III-170 free base |
|
|
|
|
| BRD-6929 |
|
|
|
99.01% |
| BRD-K98645985 |
|
|
|
99.70% |
| BRD3308 |
|
|
|
98.34% |
| BRN3OMe |
|
|
|
|
| Bromosporine |
|
|
|
99.89% |
| Bz-RS-iSer(3-Ph)-OMe |
|
|
|
99.95% |
| c-PB2(OH)2 |
|
|
|
|
| C34 peptide |
|
|
|
|
| C5A |
|
|
|
|
| CA inhibitor 1 |
|
|
|
99.77% |
| Calcium mesoxalate |
|
|
|
|
| Capravirine |
|
|
|
|
| Capsid assembly inhibitor |
|
|
|
|
| Carbenoxolone-d4 |
|
|
|
99.28% |
| Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl |
|
|
|
|
| Carbovir triphosphate |
|
|
|
|
| CB-0821 |
|
|
|
|
| CC-3052 |
|
|
|
|
| CCR5 antagonist 1 |
|
|
|
|
| CCR5 antagonist 2 |
|
|
|
|
| CCR5 antagonist 3 |
|
|
|
|
| CDK9 ligand 4 |
|
|
|
|
| CDK9-IN-1 |
|
|
|
98.52% |
| CDK9-IN-30 |
|
|
|
98.0% |
| Celgosivir |
|
|
|
|
| Celgosivir hydrochloride |
|
|
|
98.0% |
| Cenicriviroc |
|
|
|
99.51% |
| Cenicriviroc Mesylate |
|
|
|
99.94% |
| Censavudine |
|
|
|
98.00% |
| CGP 53437 |
|
|
|
|
| CGP 53820 |
|
|
|
|
| CGP 57813 |
|
|
|
|
| CGP-75355 |
|
|
|
|
| Chloropeptin I |
|
|
|
|
| CHMA1004 |
|
|
|
|
| CI-39 |
|
|
|
|
| Ciapavir |
|
|
|
|
| Circulin B |
|
|
|
|
| cis-ICeD-2 |
|
|
|
|
| CK-548 |
|
|
|
|
| CK-666 |
|
|
|
99.95% |
| CK147 |
|
|
|
|
| Claficapavir |
|
|
|
98.75% |
| Cleomiscosin B |
|
|
|
98.81% |
| CMPD167 |
|
|
|
|
| CNI-H0294 hydrochloride |
|
|
|
|
| Coccinin |
|
|
|
|
| Cosalane |
|
|
|
99.50% |
| Crotoniazide |
|
|
|
|
| CXCR4 antagonist 1 |
|
|
|
|
| CXCR4 antagonist 4 |
|
|
|
|
| CXCR4 antagonist 7 |
|
|
|
|
| Cyclotriazadisulfonamide |
|
|
|
98.45% |
| Cyclotriazadisulfonamide hydrochloride |
|
|
|
|
| Cys(Npys)-(Arg)9 |
|
|
|
|
| Cys(Npys)-(Arg)9 acetate |
|
|
|
95.15% |
| Cys(Npys)-TAT (47-57) |
|
|
|
|
| Cys-TAT(47-57) |
|
|
|
|
| Cys-TAT(47-57) TFA |
|
|
|
98.33% |
| D77 |
|
|
|
|
| DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
|
|
|
|
| DAPD-NHc-pr |
|
|
|
|
| Dapivirine hydrochloride |
|
|
|
|
| Dapivirine-d4 |
|
|
|
|
| DAPTA |
|
|
|
99.40% |
| Darunavir-d9 |
|
|
|
|
| Daurichromenic acid |
|
|
|
|
| DC20 |
|
|
|
|
| ddATP |
|
|
|
|
| ddATP lithium |
|
|
|
|
| ddATP tetrasodium |
|
|
|
|
| ddATP trisodium solution (100 mM) |
|
|
|
99.93% |
| ddCTP |
|
|
|
|
| ddCTP tetrasodium |
|
|
|
|
| ddCTP trilithium |
|
|
|
|
| ddCTP trisodium solution (100 mM) |
|
|
|
98.03% |
| ddTTP tetrasodium |
|
|
|
|
| DDX3-IN-1 |
|
|
|
99.67% |
| DDX3-IN-2 |
|
|
|
99.54% |
| Deaminase inhibitor-1 |
|
|
|
99.62% |
| Decanoyl-RVKR-CMK |
|
|
|
99.64% |
| Decanoyl-RVKR-CMK TFA |
|
|
|
97.53% |
| Decarine |
|
|
|
|
| Defensin HNP-1 human |
|
|
|
98.12% |
| Defensin HNP-1 human TFA |
|
|
|
99.08% |
| Dehydrozingerone |
|
|
|
99.98% |
| DENV-IN-5 |
|
|
|
|
| DENV-IN-6 |
|
|
|
|
| DENV-IN-7 |
|
|
|
|
| Des(benzylpyridyl) Atazanavir |
|
|
|
|
| Dexelvucitabine |
|
|
|
99.52% |
| Dezecapavir |
|
|
|
99.97% |
| DGKα-IN-8 |
|
|
|
|
| DIACC-1010 |
|
|
|
|
| Diacetylsplenopentin hydrochloride |
|
|
|
|
| Diacetylsplenopentine |
|
|
|
|
| Didanosine-13C2,15N |
|
|
|
|
| Dioxolane T |
|
|
|
|
| Ditiocarb |
|
|
|
|
| Ditiocarb sodium,98% |
|
|
|
99.2% |
| Ditiocarb-d10 |
|
|
|
|
| DLC27-14 |
|
|
|
|
| DMJ-I-228 |
|
|
|
|
| DMP-851 |
|
|
|
|
| Docosyl trans-ferulate |
|
|
|
|
| Dolutegravir intermediate-1 |
|
|
|
99.95% |
| Dox-btn2 |
|
|
|
98.80% |
| DPC 684 |
|
|
|
|
| DPC 961 |
|
|
|
|
| DPC 963 |
|
|
|
|
| DPC-082 |
|
|
|
|
| DPC-681 |
|
|
|
98.80% |
| DPP9-IN-2 |
|
|
|
|
| DQBS |
|
|
|
|
| DrkBiT |
|
|
|
|
| Droxinavir |
|
|
|
|
| Droxinavir hydrochloride |
|
|
|
|
| DS-003 |
|
|
|
|
| E913 |
|
|
|
|
| EBV-IN-1 |
|
|
|
|
| EFdA-TP |
|
|
|
|
| EFdA-TP tetraammonium |
|
|
|
|
| EFdA-TP tetralithium |
|
|
|
96.91% |
| EFdA-TP tetrasodium |
|
|
|
|
| ELDKWA |
|
|
|
|
| Elsulfavirine |
|
|
|
99.90% |
| Elsulfavirine sodium |
|
|
|
|
| Elvitegravir-13C6 |
|
|
|
|
| Elvucitabine |
|
|
|
|
| Emivirine |
|
|
|
99.73% |
| Emtricitabine S-oxide |
|
|
|
|
| Emtricitabine triphosphate |
|
|
|
|
| Emtricitabine triphosphate tetrasodium salt |
|
|
|
99.20% |
| EP39 |
|
|
|
|
| Epicoccone B |
|
|
|
|
| Ethyl salvianolate A |
|
|
|
91.38% |
| Etravirine-13C3 |
|
|
|
|
| F1839-I |
|
|
|
|
| F9170 |
|
|
|
|
| F9170 TFA |
|
|
|
99.70% |
| Fasudil dihydrochloride |
|
|
|
99.98% |
| FC-14367 |
|
|
|
|
| FC-14369 |
|
|
|
97.85% |
| FC131 |
|
|
|
|
| FC131 TFA |
|
|
|
99.87% |
| Feglymycin |
|
|
|
|
| FGF22-IN-1 |
|
|
|
98.07% |
| FGI-1011A6 |
|
|
|
|
| FGI-106 |
|
|
|
|
| FGI-106 tetrahydrochloride |
|
|
|
99.68% |
| Filgotinib |
|
|
|
99.77% |
| Filgotinib maleate |
|
|
|
99.88% |
| Fipravirimat |
|
|
|
|
| Fipravirimat dihydrochloride |
|
|
|
99.70% |
| FITC-LC-TAT (47-57) |
|
|
|
|
| FITC-LC-TAT (47-57) acetate |
|
|
|
99.06% |
| FITC-Trecovirsen sodium |
|
|
|
|
| FK-3000 |
|
|
|
|
| Fleephilone |
|
|
|
|
| Fluorescent HIV Substrate |
|
|
|
|
| FNC-TP |
|
|
|
95.0% |
| FNC-TP trisodium |
|
|
|
|
| Formycin A |
|
|
|
99.0% |
| Fosalvudine tidoxil |
|
|
|
|
| Fosamprenavir sodium |
|
|
|
|
| Fosdevirine |
|
|
|
|
| Fostemsavir |
|
|
|
99.69% |
| Fostemsavir sodium |
|
|
|
|
| Fostemsavir Tris |
|
|
|
99.78% |
| Fostemsavir-d8 |
|
|
|
|
| Fozivudine tidoxil |
|
|
|
|
| FP-21399 |
|
|
|
|
| Fuscin |
|
|
|
|
| Ganosinensic acid C |
|
|
|
|
| Gardiquimod hydrochloride |
|
|
|
|
| GB-1a |
|
|
|
|
| GCA-186 |
|
|
|
|
| Globotriaosylceramide (porcine RBC) |
|
|
|
|
| GLR-19 |
|
|
|
|
| Glurate |
|
|
|
98.54% |
| Glurate-d5 |
|
|
|
|
| Glycoborinine |
|
|
|
|
| Glycolithocholic acid 3-sulfate |
|
|
|
99.21% |
| Glycolithocholic acid 3-sulfate disodium |
|
|
|
99.73% |
| Gomisin M1 |
|
|
|
99.75% |
| GP120, HIV-1 MN |
|
|
|
|
| gp120-IN-1 |
|
|
|
|
| gp120-IN-2 |
|
|
|
|
| gp120-IN-3 |
|
|
|
|
| GPI-1046 |
|
|
|
99.79% |
| GPI2A |
|
|
|
|
| GPI2A sodium |
|
|
|
|
| GPR15 antagonist-1 |
|
|
|
99.70% |
| GPS491 |
|
|
|
|
| GRL-142 |
|
|
|
|
| GS-7339 |
|
|
|
|
| GS-9148 |
|
|
|
|
| GS-9160 |
|
|
|
|
| GS-9822 |
|
|
|
|
| GSK-1264 |
|
|
|
|
| GSK-214096 |
|
|
|
|
| GSK-364735 |
|
|
|
97.34% |
| GSK-364735 potassium |
|
|
|
|
| GSK-364735 sodium |
|
|
|
|
| GSK163929 |
|
|
|
|
| GSK2838232 |
|
|
|
98.99% |
| GSK3532795 |
|
|
|
98.0% |
| GSK3532795 hydrochloride |
|
|
|
|
| GSK3532795 oxalate |
|
|
|
|
| GSK3739936 |
|
|
|
|
| GSK5750 |
|
|
|
|
| GSK812397 |
|
|
|
|
| GSK878 |
|
|
|
|
| GUT-70 |
|
|
|
|
| GW695634 |
|
|
|
|
| Gymnin |
|
|
|
|
| H-Gly-Pro-Gly-NH2 |
|
|
|
|
| HBV Seq2 aa:179-186 |
|
|
|
|
| Hck-IN-1 |
|
|
|
98.10% |
| HEP-1 |
|
|
|
99.88% |
| HEPT |
|
|
|
|
| Herbacitrin |
|
|
|
|
| HF50731 |
|
|
|
|
| HGS004 |
|
|
|
|
| HGS101 |
|
|
|
|
| HI-207 |
|
|
|
|
| HI-236 |
|
|
|
|
| HI-253 |
|
|
|
|
| HI-280 |
|
|
|
|
| HI-346 |
|
|
|
|
| Hinnuliquinone |
|
|
|
|
| HIV capsid modulator 1 |
|
|
|
|
| HIV capsid modulator 2 |
|
|
|
|
| HIV Capsid-IN-2 |
|
|
|
|
| HIV gag peptide (197-205) |
|
|
|
|
| HIV gp120 (254-274) |
|
|
|
|
| HIV gp120 (308-331) |
|
|
|
|
| HIV gp120 (318-327) |
|
|
|
|
| HIV gp120 (421-438) |
|
|
|
|
| HIV p17 Gag (77-85) |
|
|
|
|
| HIV RT-IN-1 |
|
|
|
|
| HIV RT-IN-2 |
|
|
|
|
| HIV-1 capsid inhibitor 1 |
|
|
|
|
| HIV-1 GAG peptide A-I |
|
|
|
|
| HIV-1 gag Protein p24 (194-210) |
|
|
|
|
| HIV-1 inhibitor-10 |
|
|
|
|
| HIV-1 inhibitor-11 |
|
|
|
|
| HIV-1 inhibitor-12 |
|
|
|
|
| HIV-1 inhibitor-13 |
|
|
|
|
| HIV-1 inhibitor-14 |
|
|
|
|
| HIV-1 inhibitor-15 |
|
|
|
|
| HIV-1 inhibitor-16 |
|
|
|
|
| HIV-1 inhibitor-17 |
|
|
|
|
| HIV-1 inhibitor-18 |
|
|
|
|
| HIV-1 inhibitor-19 |
|
|
|
|
| HIV-1 inhibitor-20 |
|
|
|
|
| HIV-1 inhibitor-21 |
|
|
|
|
| HIV-1 inhibitor-22 |
|
|
|
|
| HIV-1 inhibitor-23 |
|
|
|
|
| HIV-1 inhibitor-24 |
|
|
|
|
| HIV-1 inhibitor-25 |
|
|
|
|
| HIV-1 inhibitor-26 |
|
|
|
|
| HIV-1 inhibitor-27 |
|
|
|
|
| HIV-1 inhibitor-28 |
|
|
|
|
| HIV-1 inhibitor-29 |
|
|
|
|
| HIV-1 inhibitor-3 |
|
|
|
|
| HIV-1 inhibitor-30 |
|
|
|
|
| HIV-1 inhibitor-31 |
|
|
|
|
| HIV-1 inhibitor-32 |
|
|
|
|
| HIV-1 inhibitor-33 |
|
|
|
|
| HIV-1 inhibitor-34 |
|
|
|
|
| HIV-1 inhibitor-35 |
|
|
|
|
| HIV-1 inhibitor-36 |
|
|
|
|
| HIV-1 inhibitor-37 |
|
|
|
|
| HIV-1 inhibitor-38 |
|
|
|
|
| HIV-1 inhibitor-39 |
|
|
|
|
| HIV-1 inhibitor-40 |
|
|
|
|
| HIV-1 inhibitor-41 |
|
|
|
|
| HIV-1 inhibitor-42 |
|
|
|
|
| HIV-1 inhibitor-43 |
|
|
|
|
| HIV-1 inhibitor-44 |
|
|
|
|
| HIV-1 inhibitor-45 |
|
|
|
99.54% |
| HIV-1 inhibitor-46 |
|
|
|
|
| HIV-1 inhibitor-47 |
|
|
|
98.0% |
| HIV-1 inhibitor-48 |
|
|
|
99.38% |
| HIV-1 inhibitor-49 |
|
|
|
|
| HIV-1 inhibitor-50 |
|
|
|
|
| HIV-1 inhibitor-51 |
|
|
|
|
| HIV-1 inhibitor-52 |
|
|
|
|
| HIV-1 inhibitor-54 |
|
|
|
|
| HIV-1 inhibitor-55 |
|
|
|
|
| HIV-1 inhibitor-56 |
|
|
|
|
| HIV-1 inhibitor-57 |
|
|
|
|
| HIV-1 inhibitor-58 |
|
|
|
|
| HIV-1 inhibitor-59 |
|
|
|
|
| HIV-1 inhibitor-6 |
|
|
|
99.10% |
| HIV-1 inhibitor-60 |
|
|
|
|
| HIV-1 inhibitor-61 |
|
|
|
|
| HIV-1 inhibitor-62 |
|
|
|
|
| HIV-1 inhibitor-63 |
|
|
|
|
| HIV-1 inhibitor-64 |
|
|
|
|
| HIV-1 inhibitor-65 |
|
|
|
|
| HIV-1 inhibitor-66 |
|
|
|
|
| HIV-1 inhibitor-68 |
|
|
|
|
| HIV-1 inhibitor-69 |
|
|
|
99.39% |
| HIV-1 inhibitor-70 |
|
|
|
|
| HIV-1 inhibitor-71 |
|
|
|
|
| HIV-1 inhibitor-72 |
|
|
|
|
| HIV-1 inhibitor-73 |
|
|
|
|
| HIV-1 inhibitor-74 |
|
|
|
|
| HIV-1 inhibitor-75 |
|
|
|
|
| HIV-1 inhibitor-76 |
|
|
|
|
| HIV-1 inhibitor-77 |
|
|
|
|
| HIV-1 inhibitor-78 |
|
|
|
|
| HIV-1 inhibitor-79 |
|
|
|
|
| HIV-1 inhibitor-8 |
|
|
|
98.03% |
| HIV-1 inhibitor-80 |
|
|
|
|
| HIV-1 inhibitor-81 |
|
|
|
|
| HIV-1 inhibitor-9 |
|
|
|
|
| HIV-1 integrase inhibitor |
|
|
|
97.06% |
| HIV-1 integrase inhibitor 3 |
|
|
|
|
| HIV-1 integrase inhibitor 4 |
|
|
|
|
| HIV-1 integrase inhibitor 9 |
|
|
|
|
| HIV-1 Nef-IN-1 |
|
|
|
98.60% |
| HIV-1 protease-IN-1 |
|
|
|
|
| HIV-1 protease-IN-10 |
|
|
|
|
| HIV-1 protease-IN-15 |
|
|
|
|
| HIV-1 protease-IN-3 |
|
|
|
|
| HIV-1 protease-IN-4 |
|
|
|
|
| HIV-1 protease-IN-6 |
|
|
|
|
| HIV-1 Rev (34-50) |
|
|
|
|
| HIV-1 TAT (48-60) |
|
|
|
99.78% |
| HIV-1 tat Protein (1-9) |
|
|
|
|
| HIV-1-IN-82 |
|
|
|
|
| HIV-1-IN-83 |
|
|
|
|
| HIV-1-IN-84 |
|
|
|
|
| HIV-1-IN-85 |
|
|
|
|
| HIV-1-IN-86 |
|
|
|
|
| HIV-1-IN-87 |
|
|
|
|
| HIV-1-IN-88 |
|
|
|
|
| HIV-1-IN-89 |
|
|
|
|
| HIV-1-IN-90 |
|
|
|
|
| HIV-1-IN-92 |
|
|
|
|
| HIV-1-IN-93 |
|
|
|
|
| HIV-2 Peptide |
|
|
|
|
| HIV-IN petide |
|
|
|
|
| HIV-IN-1 |
|
|
|
|
| HIV-IN-10 |
|
|
|
|
| HIV-IN-12 |
|
|
|
|
| HIV-IN-13 |
|
|
|
|
| HIV-IN-13 prodrug |
|
|
|
|
| HIV-IN-2 |
|
|
|
|
| HIV-IN-3 |
|
|
|
|
| HIV-IN-4 |
|
|
|
|
| HIV-IN-5 |
|
|
|
|
| HIV-IN-6 |
|
|
|
98.35% |
| HIV-IN-8 |
|
|
|
|
| HIV-IN-9 |
|
|
|
|
| HODHBt |
|
|
|
99.34% |
| Hydroxydihydrobovolide |
|
|
|
|
| Hydroxyurea-15N |
|
|
|
|
| Hypoglaunine D |
|
|
|
|
| Hyrtiosal |
|
|
|
|
| I-XW-053 |
|
|
|
99.71% |
| I-XW-053 sodium |
|
|
|
|
| IC-1k |
|
|
|
|
| Icariside D2 |
|
|
|
98.0% |
| ICeD-2 |
|
|
|
|
| Ilimaquinone |
|
|
|
98.0% |
| IMB-26 |
|
|
|
98.09% |
| IMB-301 |
|
|
|
99.08% |
| IN-RNA-IN-2 |
|
|
|
|
| INCB9471 |
|
|
|
|
| Indinavir-13C4,15N |
|
|
|
|
| Indole-2-carboxylic acid |
|
|
|
99.86% |
| INDOPY-1 |
|
|
|
|
| Influenza antiviral conjugate-1 |
|
|
|
|
| Ingenol 20-palmitate |
|
|
|
|
| Ingenol 3-Hexanoate |
|
|
|
|
| Ingenol-3-palmitate |
|
|
|
99.65% |
| Inophyllum B |
|
|
|
|
| Inosine pranobex |
|
|
|
99.59% |
| Integracin B |
|
|
|
|
| Interiorin |
|
|
|
99.24% |
| InteriotherinA |
|
|
|
|
| iPAF1C |
|
|
|
99.59% |
| IQP-0528 |
|
|
|
99.90% |
| Islatravir |
|
|
|
99.67% |
| Isoapetalic acid |
|
|
|
|
| Isoquinoline |
|
|
|
99.28% |
| IT1t |
|
|
|
|
| IT1t dihydrochloride |
|
|
|
99.77% |
| ITI-367 |
|
|
|
|
| JE-2147 |
|
|
|
|
| JLJ648 |
|
|
|
|
| JRC-I-191 |
|
|
|
|
| JTK-101 |
|
|
|
|
| K-5a2 |
|
|
|
|
| Kadsulignan N |
|
|
|
|
| Kadsuracoccinic acid A |
|
|
|
|
| Kadsuralignan A |
|
|
|
|
| Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside |
|
|
|
99.09% |
| KFA-027 |
|
|
|
|
| KNI-102 |
|
|
|
|
| KP-1212 |
|
|
|
|
| KP-1461 |
|
|
|
|
| KRH-3955 |
|
|
|
|
| KRH-3955 hydrochloride |
|
|
|
|
| KRL74 |
|
|
|
|
| Kuguacin N |
|
|
|
|
| L 694746 |
|
|
|
|
| L 696229 |
|
|
|
|
| L 697661 |
|
|
|
|
| L 738372 |
|
|
|
|
| L-2'-Fd4C |
|
|
|
|
| L-697639 |
|
|
|
|
| L-702007 |
|
|
|
|
| L-708906 |
|
|
|
|
| L-738872 |
|
|
|
|
| L-739594 |
|
|
|
|
| L-870810 |
|
|
|
|
| L-Fd4A |
|
|
|
|
| L-Ristosamine nucleoside |
|
|
|
|
| L-Cycloserine |
|
|
|
98.84% |
| L-Chicoric Acid |
|
|
|
99.85% |
| Lafuvitug |
|
|
|
98.657% |
| Lamivudine-13C,15N2 |
|
|
|
|
| Lamivudine-13C,15N2,d2 |
|
|
|
|
| Lamivudine-13C,15N3 |
|
|
|
|
| Lancifodilactone F |
|
|
|
|
| Lancifodilactone N |
|
|
|
|
| LDC4297 |
|
|
|
99.74% |
| LDC4297 hydrochloride |
|
|
|
98.23% |
| LEDGIN6 |
|
|
|
99.62% |
| Lefelsiran sodium scrambled negative control |
|
|
|
|
| Lenacapavir |
|
|
|
98.44% |
| Lenacapavir pacfosacil |
|
|
|
|
| Lenacapavir sodium |
|
|
|
99.86% |
| Lenacapavir-d5 |
|
|
|
|
| Lepetegravir |
|
|
|
|
| Lersivirine |
|
|
|
98.36% |
| LJ001 |
|
|
|
98.04% |
| Lucidenic acid O |
|
|
|
|
| Lucidenic lactone |
|
|
|
|
| Luzopeptin A |
|
|
|
|
| LY-326188 |
|
|
|
|
| LY-73497 |
|
|
|
|
| Maraviroc-d6 |
|
|
|
|
| Marsdenoside F |
|
|
|
|
| Mavorixafor |
|
|
|
99.66% |
| Mavorixafor hydrochloride |
|
|
|
99.64% |
| Mavorixafor trihydrochloride |
|
|
|
99.75% |
| MB-66 |
|
|
|
|
| mC46 peptide |
|
|
|
|
| Melanochromone |
|
|
|
|
| Melliferone |
|
|
|
|
| Mer-NF5003E |
|
|
|
|
| Methyl gallate |
|
|
|
99.97% |
| Methyl salvionolate A |
|
|
|
|
| Methyl-Hesperidin |
|
|
|
98.29% |
| Methyl-Hesperidin (Standard) |
|
|
|
|
| MIV-150 |
|
|
|
|
| MK-0536 |
|
|
|
|
| MK-2048 |
|
|
|
|
| MK-4965 |
|
|
|
|
| MK-8527 |
|
|
|
99.02% |
| ML416 |
|
|
|
|
| Morin 3-O-β-D-glucopyranoside |
|
|
|
|
| Mozenavir |
|
|
|
|
| MPG peptides, Pβ |
|
|
|
98.26% |
| MPG, HIV related |
|
|
|
|
| MS417 |
|
|
|
99.79% |
| Murabutide |
|
|
|
|
| N-Choloylphenylalanine |
|
|
|
|
| N.41 |
|
|
|
|
| N36 peptide |
|
|
|
|
| N36Mut(e,g) |
|
|
|
|
| NB-64 |
|
|
|
|
| NBD-10007 |
|
|
|
|
| NBD-14189 |
|
|
|
99.84% |
| NBD-14270 |
|
|
|
99.53% |
| NBD-556 |
|
|
|
99.57% |
| NBD-557 |
|
|
|
99.41% |
| Nef ligand-1 |
|
|
|
|
| Nef ligand-2 |
|
|
|
|
| Neoaspidistrin |
|
|
|
|
| Neotripterifordin |
|
|
|
|
| NF279 |
|
|
|
98.5% |
| Niglizin |
|
|
|
|
| Nigranoic acid |
|
|
|
95.0% |
| Nipamovir |
|
|
|
98.60% |
| Niruriside |
|
|
|
|
| NNRT-IN-1 |
|
|
|
|
| NNRT-IN-10 |
|
|
|
|
| NNRT-IN-11 |
|
|
|
|
| NNRT-IN-12 |
|
|
|
|
| NNRT-IN-13 |
|
|
|
|
| NNRT-IN-14 |
|
|
|
|
| NNRT-IN-15 |
|
|
|
|
| NNRT-IN-16 |
|
|
|
|
| NNRT-IN-2 |
|
|
|
|
| NNRT-IN-4 |
|
|
|
|
| NNRT-IN-6 |
|
|
|
|
| NNRT-IN-8 |
|
|
|
|
| NNRT-IN-9 |
|
|
|
|
| Nonoxynol-9 |
|
|
|
|
| NPD4456 |
|
|
|
|
| NSC 13987 |
|
|
|
|
| NSC260594 |
|
|
|
97.50% |
| NSC727447 |
|
|
|
95.0% |
| NYAD-13 |
|
|
|
|
| Obefazimod |
|
|
|
99.85% |
| OICR409946 |
|
|
|
|
| Oltipraz (GMP) |
|
|
|
|
| ONX-0914 |
|
|
|
99.72% |
| ONX-0914 TFA |
|
|
|
98.01% |
| Ophiobolin C |
|
|
|
|
| Orthosporin |
|
|
|
|
| Oxindole |
|
|
|
99.59% |
| P-1946 |
|
|
|
|
| Panobinostat lactate |
|
|
|
98.67% |
| PAP 248-286 |
|
|
|
|
| PAP 248-286 acetate |
|
|
|
|
| Patentiflorin A |
|
|
|
|
| PB(OH)3 |
|
|
|
|
| PD 161374 |
|
|
|
|
| PD-159206 |
|
|
|
|
| Peginterferon alfa-2b |
|
|
|
≥99.0% |
| Peldesine |
|
|
|
|
| Peldesine dihydrochloride |
|
|
|
99.28% |
| Pentosan Polysulfate |
|
|
|
|
| Pentosan Polysulfate Sodium (W/W 43%) |
|
|
|
43% |
| Peptide T |
|
|
|
98.68% |
| Peptide T TFA |
|
|
|
|
| Periglaucine A |
|
|
|
|
| Peritassine A |
|
|
|
|
| PF-00835231 |
|
|
|
99.31% |
| PF-232798 |
|
|
|
|
| PF-3450074 |
|
|
|
98.89% |
| PF-46396 |
|
|
|
|
| PF-4776548 |
|
|
|
|
| Phorbol-12,13-didecanoate |
|
|
|
98.22% |
| Pimelautide |
|
|
|
|
| Pirmitegravir |
|
|
|
99.79% |
| PMEDAP |
|
|
|
98.0% |
| PNU-103017 |
|
|
|
|
| PNU-103657 |
|
|
|
|
| PNU‐142721 |
|
|
|
|
| Pol (476-484), HIV-1 RT Epitope |
|
|
|
|
| POSH-IN-1 |
|
|
|
99.71% |
| Pradimicin A |
|
|
|
|
| Prostratin |
|
|
|
99.60% |
| PROTAC BRD4 Degrader-43 |
|
|
|
|
| PROTAC CDK9 degrader-12 |
|
|
|
|
| PROTAC CG167 |
|
|
|
|
| PROTAC SAMHD1 Degrader-1 |
|
|
|
|
| PROTAC Vif degrader-1 |
|
|
|
|
| Pseudothymidine |
|
|
|
99.44% |
| PTACH |
|
|
|
97.04% |
| PTP1B-IN-25 |
|
|
|
|
| PYR01 |
|
|
|
99.86% |
| Pyrazofurin |
|
|
|
97.16% |
| Q-VD-OPh |
|
|
|
99.90% |
| Q-VD-OPh |
|
|
|
|
| QYL-685 |
|
|
|
|
| R-82150 |
|
|
|
|
| R82913 |
|
|
|
|
| Raltegravir-d4 potassium |
|
|
|
|
| RDEA 806 |
|
|
|
|
| RDEA-427 |
|
|
|
|
| Redoxal |
|
|
|
|
| rel-Emtricitabine |
|
|
|
|
| Retrocyclin-1 |
|
|
|
|
| Retrocyclin-101 |
|
|
|
|
| Retrocyclin-101 TFA |
|
|
|
96.69% |
| Reverse transcriptase-IN-1 |
|
|
|
98.08% |
| Reverse transcriptase-IN-3 |
|
|
|
|
| Reverse transcriptase-IN-4 |
|
|
|
|
| Rhuscholide A |
|
|
|
|
| RIG-1 modulator 1 |
|
|
|
99.54% |
| RIG-1 modulator 1 (Standard) |
|
|
|
|
| Rilpivirine-d6 hydrochloride |
|
|
|
|
| RJS308 |
|
|
|
99.62% |
| RJS308 TFA |
|
|
|
98.36% |
| RM-5038 |
|
|
|
|
| RN-18 |
|
|
|
98.75% |
| Ro24-7429 |
|
|
|
99.85% |
| Rottlerin |
|
|
|
98.45% |
| Rovafovir etalafenamide |
|
|
|
99.85% |
| Rp-dGTPαS |
|
|
|
|
| Rp-TTPαS tetrasodium |
|
|
|
|
| RPR103611 |
|
|
|
|
| S 1360 |
|
|
|
|
| S-2720 |
|
|
|
|
| Salaspermic acid |
|
|
|
|
| Salicylanilide |
|
|
|
98.14% |
| Salvianan A |
|
|
|
|
| SAMHD1 ligand-1 |
|
|
|
|
| SAMT-247 |
|
|
|
|
| Saquinavir-13C6 |
|
|
|
|
| SARS-CoV-IN-2 |
|
|
|
98.66% |
| SARS-CoV-IN-3 |
|
|
|
99.36% |
| SB 204144 |
|
|
|
|
| SC-49483 |
|
|
|
|
| Schineolignin B |
|
|
|
98.25% |
| Schineolignin C |
|
|
|
|
| Schinlignan B |
|
|
|
|
| Schizanrin D |
|
|
|
|
| Scirpusin A |
|
|
|
|
| SDZ283-910 |
|
|
|
|
| Seletracetam lithium |
|
|
|
|
| Semzuvolimab |
|
|
|
97% |
| Siamycin I |
|
|
|
|
| Siamycin III |
|
|
|
|
| Sifuvirtide |
|
|
|
|
| Sifuvirtide acetate |
|
|
|
99.82% |
| SJ-3366 |
|
|
|
|
| SJP-L-5 |
|
|
|
|
| SMAPP1 |
|
|
|
99.43% |
| Soulattrolide |
|
|
|
|
| soVIRIP |
|
|
|
|
| Soyasaponin II |
|
|
|
99.81% |
| Sp-TTPαS |
|
|
|
|
| Sp-TTPαS tetrasodium |
|
|
|
|
| Sparstolonin B |
|
|
|
99.94% |
| SRI-32743 |
|
|
|
|
| SRI-45949 |
|
|
|
|
| ssRNA40 sodium |
|
|
|
98.34% |
| ST7612AA1 |
|
|
|
|
| Stachybotrylactam |
|
|
|
|
| Stampidine |
|
|
|
99.96% |
| Suberosol |
|
|
|
|
| Suksdorfin |
|
|
|
|
| Sulfametrole |
|
|
|
99.54% |
| T-22 |
|
|
|
|
| T-peptide |
|
|
|
|
| T326 |
|
|
|
|
| Tachyplesin II |
|
|
|
|
| TAK-220 |
|
|
|
99.94% |
| TAK-779 |
|
|
|
99.89% |
| Talviraline |
|
|
|
|
| TAT |
|
|
|
99.92% |
| TAT (47-57), FAM-labeled |
|
|
|
|
| TAT (47-57), FAM-labeled acetate |
|
|
|
|
| TAT (48-57) |
|
|
|
98.23% |
| TAT (48-57) TFA |
|
|
|
|
| TAT acetate |
|
|
|
98.66% |
| TAT peptide |
|
|
|
|
| TAT peptide TFA |
|
|
|
99.83% |
| TAT TFA |
|
|
|
99.70% |
| Tat-beclin 1 |
|
|
|
99.89% |
| Tat-beclin 1 scrambled |
|
|
|
99.10% |
| Tat-beclin 1 scrambled TFA |
|
|
|
96.26% |
| Tat-beclin 1 TFA |
|
|
|
|
| TAT-CBD3 |
|
|
|
|
| Tat-CBD3 TFA |
|
|
|
|
| TAT-GluR23A Fusion Peptide |
|
|
|
|
| Tat-HA-NR2B9c |
|
|
|
|
| TAT-NSF700scr |
|
|
|
95.17% |
| TC14012 |
|
|
|
99.77% |
| TC14012 TFA |
|
|
|
|
| TEI-2306 |
|
|
|
|
| Teicoplanin sodium |
|
|
|
|
| Temporin-SHa |
|
|
|
|
| Temsavir |
|
|
|
98.70% |
| Tenofovir alafenamide-d5 fumarate |
|
|
|
|
| Tenofovir diphosphate disodium |
|
|
|
97.68% |
| Tenofovir disoproxil aspartate |
|
|
|
|
| Tenofovir exalidex |
|
|
|
99.82% |
| Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium |
|
|
|
|
| Tenofovir-C3-O-C15-CF3 ammonium |
|
|
|
|
| Terpestacin |
|
|
|
|
| TH6342 |
|
|
|
99.15% |
| Thiazolobenzimidazole |
|
|
|
|
| Tifuvirtide |
|
|
|
|
| Tivirapine |
|
|
|
|
| TLR8 agonist 10 |
|
|
|
|
| TMC-126 |
|
|
|
|
| TNK-651 |
|
|
|
|
| TNT-i |
|
|
|
|
| Trecovirsen |
|
|
|
97.98% |
| Trecovirsen sodium |
|
|
|
96.55% |
| Trecovirsen sodium scrambled negative control |
|
|
|
|
| Tremuloidin |
|
|
|
|
| Triciribine |
|
|
|
98.62% |
| Triptonine B |
|
|
|
|
| TSAO-T |
|
|
|
|
| Tsugafolin |
|
|
|
|
| TWH106 |
|
|
|
|
| TX-1918 |
|
|
|
|
| U 80493 |
|
|
|
|
| U 88204 |
|
|
|
|
| U 95133 |
|
|
|
|
| U-104489 |
|
|
|
|
| U-89360E |
|
|
|
|
| U-96988 |
|
|
|
|
| UC-38 |
|
|
|
|
| UC-781 |
|
|
|
|
| UC-84 |
|
|
|
|
| UK-88947 hydrochloride |
|
|
|
|
| Ulonivirine |
|
|
|
98.61% |
| UMB-136 |
|
|
|
|
| Uncaric acid |
|
|
|
|
| Urushiol (15:3) |
|
|
|
|
| Valproic acid sodium |
|
|
|
|
| Valproic acid sodium (2:1) |
|
|
|
|
| VCH-286 |
|
|
|
|
| VGD020 |
|
|
|
|
| Vicriviroc |
|
|
|
|
| Vicriviroc malate |
|
|
|
|
| Vicriviroc maleate |
|
|
|
98.49% |
| Vif-ElonginC interaction inhibitor 1 |
|
|
|
|
| VIP (1-12), human, porcine, rat, ovine |
|
|
|
|
| VIR-165 |
|
|
|
|
| VIRIP |
|
|
|
|
| Vpr (1-14) |
|
|
|
|
| VRC-01 |
|
|
|
99.805% |
| VRC01LS |
|
|
|
98.78% |
| VRX-480773 |
|
|
|
|
| Wikstrol A |
|
|
|
|
| Wikstrol B |
|
|
|
|
| Withacoagin |
|
|
|
|
| WR 151327 |
|
|
|
|
| WRNA10 |
|
|
|
|
| XQ2 |
|
|
|
|
| YYA-021 |
|
|
|
98.96% |
| Zidovudine diphosphate |
|
|
|
|
| ZINC04177596 |
|
|
|
|
| ZINC36617540 |
|
|
|
|
| Zinlirvimab |
|
|
|
98.87% |
| Zintevir |
|
|
|
|
| Zintevir sodium |
|
|
|
|
| Zintevir sodium scrambled negative control |
|
|
|
|
| ZK-316 |
|
|
|
|
| ZL0580 |
|
|
|
99.42% |
| ZLM-66 |
|
|
|
|
| ZP7 |
|
|
|
|
| α-Lipoic Acid |
|
|
|
99.94% |
| α-Lipoic Acid-d5 |
|
|
|
98.11% |
| α-Lipoic Acid (Standard) |
|
|
|
99.90% |
| α-Lipoic Acid sodium |
|
|
|
99.95% |
| β-Rubromycin |
|
|
|
97.7% |
| Beta-Acetoxyisovalerylshikonin |
|
|
|
99.57% |
| Trilobatin |
|
|
|
98.90% |
| Valproic acid-d15 |
|
|
|
99.80% |
| Valproic acid-d4 |
|
|
|
98.0% |
| Valproic acid-d4 sodium |
|
|
|
|
| Valproic acid-d6 |
|
|
|
98.0% |
| Valproic acid-d4-1 |
|
|
|
99.5% |
| Valproic acid |
|
|
|
99.90% |
| Valproic acid-d14 sodium |
|
|
|
96.73% |
| Valproic acid sodium |
|
|
|
99.65% |
| Valproic acid magnesium |
|
|
|
|
| Probenecid-d14 |
|
|
|
99.54% |
| Probenecid-d7 |
|
|
|
|
| Probenecid |
|
|
|
99.94% |
| Mesoxalate |
|
|
|
|
| Leronlimab |
|
|
|
98.91% |
| Acetohydroxamic acid |
|
|
|
99.91% |
| Acetyl-pepstatin |
|
|
|
|
| Ditiocarb sodium |
|
|
|
99.78% |
| Sodium diethylcarbamodithioate trihydrate |
|
|
|
98.0% |
| Sodium diethylcarbamodithioate trihydrate, ACS, 99.0% |
|
|
|
|
| Diphyllin |
|
|
|
99.57% |
| Dimercaprol |
|
|
|
98.01% |
| Thiamine disulfide |
|
|
|
99.54% |
| Ditiocarb-d10 sodium |
|
|
|
|
| Gomisin M2 |
|
|
|
99.75% |
| Schisantherin D |
|
|
|
99.66% |
| Ivermectin |
|
|
|
98.28% |
| Pseudohypericin |
|
|
|
99.23% |
| Ebselen |
|
|
|
99.80% |
| Elipovimab |
|
|
|
97.64% |
| Etravirine |
|
|
|
99.07% |
| Etravirine-d4 |
|
|
|
98.31% |
| Etravirine-d8 |
|
|
|
|
| Efavirenz-13C6 |
|
|
|
|
| Efavirenz-d5 |
|
|
|
|
| (Rac)-Efavirenz-d4 |
|
|
|
|
| Efavirenz |
|
|
|
99.93% |
| Glabranine |
|
|
|
99.35% |
| Clenoliximab |
|
|
|
|
| Rilpivirine-d6 |
|
|
|
|
| Rilpivirine-13C6 |
|
|
|
|
| Rilpivirine |
|
|
|
99.67% |
| Ritonavir-d6 |
|
|
|
98.84% |
| Ritonavir-13C,d3 |
|
|
|
|
| Ritonavir-13C3 |
|
|
|
|
| Ritonavir-d8 |
|
|
|
|
| Ritonavir |
|
|
|
99.96% |
| Tenofovir alafenamide hemifumarate |
|
|
|
99.92% |
| Cabotegravir |
|
|
|
99.92% |
| Cabotegravir-d5 |
|
|
|
99.31% |
| Cabotegravir-d6 |
|
|
|
|
| Cabotegravir sodium |
|
|
|
99.87% |
| Carrageenan |
|
|
|
|
| Didanosine-d2 |
|
|
|
|
| Didanosine |
|
|
|
99.45% |
| trans-2-Methoxycinnamic acid |
|
|
|
99.06% |
| Cobicistat-d8 |
|
|
|
|
| Cobicistat |
|
|
|
99.49% |
| Sodium copper chlorophyllin B |
|
|
|
|
| Stavudine |
|
|
|
99.89% |
| Stavudine-d4 |
|
|
|
|
| Stavudine sodium |
|
|
|
99.40% |
| Oltipraz-d3 |
|
|
|
|
| Oltipraz |
|
|
|
99.71% |
| Rolipram |
|
|
|
99.87% |
| Linarin |
|
|
|
98.02% |
| Delavirdine mesylate |
|
|
|
99.73% |
| Delavirdine |
|
|
|
99.70% |
| Elvitegravir-d5 |
|
|
|
|
| Elvitegravir |
|
|
|
99.90% |
| Elvitegravir-d6 |
|
|
|
|
| Elvitegravir-d8 |
|
|
|
|
| Doravirine |
|
|
|
99.79% |
| Doravirine-13C,d3 |
|
|
|
98.73% |
| Flavopiridol |
|
|
|
99.68% |
| Flavopiridol Hydrochloride |
|
|
|
99.73% |
| Fosamprenavir-13C6 |
|
|
|
|
| Fosamprenavir-d4 |
|
|
|
|
| Fosamprenavir |
|
|
|
98.17% |
| Nelfinavir-d4 |
|
|
|
|
| Nelfinavir |
|
|
|
99.64% |
| Nevirapine-d3 |
|
|
|
99.62% |
| Nevirapine-d4 |
|
|
|
|
| Nevirapine-d8 |
|
|
|
|
| Nevirapine |
|
|
|
98.19% |
| Azulene |
|
|
|
99.97% |
| Zingibroside R1 |
|
|
|
99.47% |
| Amprenavir-d4 |
|
|
|
|
| Amprenavir |
|
|
|
99.55% |
| Amprenavir-d4-1 |
|
|
|
|
| Dimethyl fumarate |
|
|
|
99.95% |
| Dimethyl fumarate-d2 |
|
|
|
98.19% |
| Berberrubine chloride |
|
|
|
99.28% |
| Nifeviroc |
|
|
|
99.39% |
| Kaempferol |
|
|
|
99.92% |
| Maslinic acid |
|
|
|
99.87% |
| Pentoxifylline-d5 |
|
|
|
99.89% |
| Pentoxifylline-d6 |
|
|
|
99.0% |
| Pentoxifylline-d3 |
|
|
|
|
| Pentoxifylline |
|
|
|
99.92% |
| Tigloylgomisin P |
|
|
|
98.36% |
| Panobinostat |
|
|
|
99.37% |
| Panobinostat-d4 |
|
|
|
|
| Panobinostat-d4 hydrochloride |
|
|
|
|
| Dolutegravir-d3 |
|
|
|
99.64% |
| Dolutegravir-d5 |
|
|
|
|
| Dolutegravir |
|
|
|
99.94% |
| Dolutegravir sodium |
|
|
|
99.97% |
| Isoquinoline-15N |
|
|
|
|
| Isochlorogenic acid A |
|
|
|
99.53% |
| Enfuvirtide |
|
|
|
99.93% |
| Emtricitabine |
|
|
|
99.97% |
| Emtricitabine-15N,d2 |
|
|
|
97.64% |
| Emtricitabine-13C,15N2 |
|
|
|
|
| Emtricitabine-d2 |
|
|
|
|
| Gomisin G |
|
|
|
99.93% |
| Zalcitabine |
|
|
|
99.81% |
| Lamivudine |
|
|
|
99.97% |
| Lamivudine-15N,d2 |
|
|
|
|
| Lamivudine salicylate |
|
|
|
|
| Plerixafor |
|
|
|
99.90% |
| Plerixafor-d4 |
|
|
|
|
| Trovirdine |
|
|
|
98.62% |
| Telinavir |
|
|
|
98.16% |
| Tizoxanide |
|
|
|
99.97% |
| Tizoxanide-d4 |
|
|
|
99.79% |
| Tipranavir |
|
|
|
98.0% |
| Tipranavir-d5 |
|
|
|
|
| Tipranavir-d7 |
|
|
|
98.94% |
| Teropavimab |
|
|
|
99.70% |
| Tenofovir |
|
|
|
99.92% |
| Tenofovir diphosphate |
|
|
|
|
| Tenofovir diphosphate triethylamine |
|
|
|
|
| Tenofovir Disoproxil fumarate |
|
|
|
99.62% |
| Tenofovir hydrate |
|
|
|
99.53% |
| Tenofovir alafenamide |
|
|
|
99.93% |
| Tenofovir alafenamide-d6 |
|
|
|
|
| Tenofovir alafenamide fumarate |
|
|
|
99.87% |
| Tenofovir Disoproxil |
|
|
|
99.52% |
| Tenofovir maleate |
|
|
|
|
| Calceolarioside A |
|
|
|
|
| Leptomycin A |
|
|
|
|
| Letrazuril |
|
|
|
98.79% |
| Letrazuril (Standard) |
|
|
|
|
| Limonin |
|
|
|
99.38% |
| Kuwanon L |
|
|
|
|
| Imperatorin-d6 |
|
|
|
|
| 13-Oxyingenol-13-dodecanoate |
|
|
|
95.73% |
| Birinapant |
|
|
|
99.70% |
| Amdoxovir |
|
|
|
|
| Lysozyme chloride |
|
|
|
|
| Chloroquine |
|
|
|
99.50% |
| Chloroquine-d5 |
|
|
|
99.90% |
| Saquinavir-d9 |
|
|
|
|
| Saquinavir |
|
|
|
99.77% |
| Saquinavir mesylate |
|
|
|
99.40% |
| Lopinavir |
|
|
|
99.71% |
| Lopinavir-d7 |
|
|
|
|
| Lopinavir-d8 |
|
|
|
|
| Lobucavir |
|
|
|
|
| Loviride |
|
|
|
99.59% |
| Fumagillin |
|
|
|
95.04% |
| Phellopterin |
|
|
|
99.94% |
| Erythromycin ethylsuccinate-13C,d3 |
|
|
|
|
| Erythromycin Ethylsuccinate |
|
|
|
79.0% |
| CHMA1004 dihydrochloride |
|
|
|
99.38% |
| Nelfinavir Mesylate |
|
|
|
99.04% |
| Sennoside A |
|
|
|
99.66% |
| Sennoside A (Standard) |
|
|
|
98.81% |
| Betulinic acid-d3 |
|
|
|
99% |
| Betulinic acid |
|
|
|
99.88% |
| Amphotericin B methyl ester hydrochloride |
|
|
|
|
| Plerixafor octahydrochloride |
|
|
|
99.09% |
| Chloroquine dihydrochloride |
|
|
|
99.61% |
| Fasudil Hydrochloride |
|
|
|
99.97% |
| Fasudil hydrochloride semihydrate |
|
|
|
|
| Bromhexine hydrochloride |
|
|
|
99.93% |
| Bromhexine-d3 hydrochloride |
|
|
|
99.0% |
| Deoxymannojirimycin hydrochloride |
|
|
|
|
| Trigonelline-d3-1 chloride |
|
|
|
|
| Trigonelline chloride |
|
|
|
99.88% |
| Doxorubicin hydrochloride |
|
|
|
99.90% |
| Indinavir sulfate |
|
|
|
99.97% |
| Dextran sulfate sodium salt (MW 5000) |
|
|
|
99.20% |
| Dextran sulfate sodium salt (MW 4500-5500) |
|
|
|
|
| Dextran sulfate sodium salt (MW 450000-550000) |
|
|
|
|
| Dextran sulfate sodium salt (MW 6500-10000) |
|
|
|
|
| Abacavir sulfate |
|
|
|
99.93% |
| Atazanavir sulfate |
|
|
|
99.68% |
| L-α-Phosphatidylinositol |
|
|
|
|
| Chloroquine-d4 phosphate |
|
|
|
|
| Chloroquine-d5 diphosphate |
|
|
|
|
| Chloroquine phosphate (Standard) |
|
|
|
99.67% |
| Chloroquine phosphate |
|
|
|
99.89% |
| Sulfadoxine |
|
|
|
98.64% |
| Sulfadoxine-d4 |
|
|
|
98.0% |
| Neuraminidase, arthrobacter ureafaciens |
|
|
|
|
| Fosamprenavir Calcium Salt |
|
|
|
98.21% |
| Fosamprenavir Calcium Salt (Standard) |
|
|
|
95% |
| Hypocrellin A |
|
|
|
99.73% |
| Mitoguazone |
|
|
|
99.23% |
| Miltefosine |
|
|
|
99.92% |
| Miltefosine-d4 |
|
|
|
|
| Corydine |
|
|
|
99.93% |
| Shikonin |
|
|
|
99.71% |
| Vesatolimod |
|
|
|
99.90% |
| Hydroxyurea |
|
|
|
99.34% |
| Cholesterol heptanoic acid |
|
|
|
|
| Trigonelline |
|
|
|
99.95% |
| Suvizumab |
|
|
|
≥99.0% |
| Ibalizumab |
|
|
|
99.74% |
| Bryostatin 1 |
|
|
|
99.70% |
| Curromycin A |
|
|
|
|
| Curromycin B |
|
|
|
|
| Aloperine |
|
|
|
99.80% |
| Benfotiamine |
|
|
|
99.38% |
| Indinavir-d6 |
|
|
|
|
| Indinavir |
|
|
|
99.96% |
| Indinavir sulfate ethanolate |
|
|
|
|
| ALizarin complexone dihydrate |
|
|
|
|
| Xanthopurpurin |
|
|
|
97.03% |
| Theaflavin 3,3'-digallate |
|
|
|
99.89% |
| Aurothioglucose |
|
|
|
96.1% |
| Myriceric acid B |
|
|
|
|
| Psoralen |
|
|
|
99.96% |
| Cedelizumab |
|
|
|
|
| Dapivirine |
|
|
|
99.80% |
| Dapivirine-d11 |
|
|
|
|
| Darunavir |
|
|
|
99.91% |
| Darunavir Ethanolate |
|
|
|
99.93% |
| Enfuvirtide acetate |
|
|
|
99.89% |
| Megestrol acetate-d3 |
|
|
|
|
| Megestrol acetate-d3-1 |
|
|
|
|
| Megestrol acetate |
|
|
|
99.69% |
| Scutellarin |
|
|
|
99.57% |
| Fangchinoline |
|
|
|
99.90% |
| Abacavir-d4 |
|
|
|
|
| Abacavir |
|
|
|
99.88% |
| Abacavir monosulfate |
|
|
|
98.86% |
| rel-Carbovir monophosphate |
|
|
|
|
| Apabetalone |
|
|
|
99.34% |
| Atazanavir |
|
|
|
99.12% |
| Atazanavir-d15 |
|
|
|
|
| Atazanavir-d18 |
|
|
|
|
| Atazanavir-d24 |
|
|
|
|
| Atazanavir-d5 |
|
|
|
|
| Atazanavir-d6 |
|
|
|
99.28% |
| Atazanavir-d9 |
|
|
|
|
| Aprepitant |
|
|
|
99.82% |
| Wilfortrine |
|
|
|
98.83% |
| Tripterifordin |
|
|
|
98.00% |
| Raltegravir-d4 |
|
|
|
|
| Raltegravir-d6 |
|
|
|
|
| Raltegravir |
|
|
|
99.82% |
| Raltegravir sodium |
|
|
|
|
| Raltegravir-d3 potassium |
|
|
|
|
| Raltegravir-13C,d3 potassium |
|
|
|
|
| Raltegravir potassium |
|
|
|
99.82% |
| Maraviroc |
|
|
|
99.98% |
| Lysozyme from chicken egg white |
|
|
|
|
| Baicalin |
|
|
|
98.92% |
| Oleanonic acid |
|
|
|
99.91% |
| Oleanolic acid-d3 |
|
|
|
98.78% |
| Oleanolic acid |
|
|
|
99.76% |
| Zidovudine-d3 |
|
|
|
|
| Zidovudine-13C,d3 |
|
|
|
93.73% |
| Zidovudine-d4 |
|
|
|
|
| Zidovudine |
|
|
|
99.97% |